Time to Integrate Measurement Uncertainty in Hemostasis Assays: RPTH Journal Commentary
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, Editor-in-Chief of RPTH Journal, posted on LinkedIn:
”Coagulation laboratories should provide a measurement of uncertainty along with each result.
This is an important concept that should have an impact on everybody’s clinical practice.
This commentary in the RPTH Journal is short, succinct and makes the point clearly. It is time that the International Society on Thrombosis and Haemostasis (ISTH) and specifically the scientific and standardisation committees put out a position statement on this.”
Read the commentary here.
Title: Time to integrate measurement uncertainty in method comparison and interpretation of hemostasis laboratory assays
Authors: François Mullier, Isabelle Gouin-Thibault, Piet Meijer, Michael Hardy, Thomas Lecompte
Stay updated with Hemostasis Today.
-
Jun 7, 2026, 06:57Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
-
Jun 7, 2026, 05:45Nicolas Hubacz: Watching a Heart Build Its Network
-
Jun 7, 2026, 05:40New Evidence Highlights the Urgent Need for Gender-Inclusive Bleeding Disorders Research – EHC
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
-
Jun 6, 2026, 23:30Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
-
Jun 6, 2026, 18:40Igor Carvalho de Oliveira: The Hidden Genetic Risk Behind Early Heart Attacks and Strokes
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?